Icure Decides 54.6% Dilution Third-Party Allotment, Largest Shareholder Change and Management Improvement


  • Icure decided on June 29, 2026, a third-party allotment of 20,502,902 shares to Solution Cosmetic Co., Ltd., representing a 54.6% dilution relative to existing shares.
  • The issue price is 1,034 won, a 52.35% discount from the last trading price of 2,170 won before trading halt. Total proceeds are approximately 21.2 billion won, to be used for facility investment 2 billion, operating funds 16.2 billion, and debt repayment 3 billion.
  • The largest shareholder will change from Choi Young-kwon 13.6% to Solution Cosmetic 35.31% after the issuance. All new shares will be locked up for one year, with an additional one-year lock on 70% of them.
  • The company faced temporary cash strain due to a withholding tax obligation related to former CEO embezzlement, and this capital increase aims to improve financial structure and normalize operations.
  • [AI Summary]This capital increase causes severe dilution of 54.6% and a 52% discount, significantly harming existing shareholder value. Funds are allocated mainly for working capital and debt repayment, focusing on financial stability rather than growth. Although all new shares are locked for one year, the massive size of the issuance is likely to negatively impact short-term stock price.

KOSDAQ Filing Information


  • Report On Major Matters (Decision On Paid-In Capital Increase)
  • Company: Icure Pharmaceutical (175250)
  • Submission: Icure Pharmaceutical Incorporation

  • Shares: 37,558,368
  • Price: 2,170 KRW
  • Market Cap: 81.5 B KRW